HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

U Budde Selected Research

von Willebrand Diseases (von Willebrand's Disease)

1/2021Ex vivo human placental transfer study on recombinant Von Willebrand factor (rVWF).
1/2016Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.
7/2014von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.
7/2014Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in von Willebrand disease.
1/2014Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
7/2013Identification of a homozygous Cys410Ser mutation in the von Willebrand factor D2 domain causing type 2A(IIC) von Willebrand disease phenotype in an Iranian patient.
3/2013Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin.
5/2012Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.
11/2011[Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
7/2011von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


U Budde Research Topics

Disease

25von Willebrand Diseases (von Willebrand's Disease)
01/2021 - 04/2001
17Hemorrhage
07/2014 - 08/2000
8Thrombotic Thrombocytopenic Purpura
01/2014 - 01/2002
6Thrombosis (Thrombus)
06/2018 - 01/2001
6Thrombocytopenia (Thrombopenia)
05/2009 - 01/2002
5Type 1 von Willebrand Disease
09/2010 - 04/2006
3Type 2 von Willebrand Disease
07/2014 - 01/2000
2Hemophilia A (Haemophilia)
09/2013 - 01/2001
2Pulmonary Embolism
05/2009 - 08/2005
2Thrombotic Microangiopathies
12/2007 - 02/2004
2Hemolytic-Uremic Syndrome
12/2007 - 09/2004
1Hemophilia B (Haemophilia B)
09/2016
1Type 3 von Willebrand Disease
07/2014
1Spontaneous Abortion (Miscarriage)
05/2013
1Down Syndrome (Down's Syndrome)
05/2011
1Aortic Valve Stenosis (Aortic Stenosis)
02/2010
1Renal Insufficiency (Renal Failure)
05/2009
1Tetralogy of Fallot (Fallot Tetralogy)
05/2009
1Bites and Stings (Sting)
05/2007
1Epistaxis (Nosebleed)
05/2007
1Hepatorenal form of glycogen storage disease
01/2005
1Evans Syndrome
02/2004
1Hypothyroidism
06/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2001
1Monoclonal Gammopathy of Undetermined Significance
06/2001
1Multiple Myeloma
06/2001
1Myeloproliferative Disorders (Myeloproliferative Disorder)
06/2001
1Wilms Tumor (Wilm's Tumor)
06/2001

Drug/Important Bio-Agent (IBA)

28von Willebrand FactorIBA
01/2021 - 01/2000
8thiamine triphosphorate (TTP)IBA
01/2014 - 01/2002
5AntigensIBA
01/2016 - 06/2001
5Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
03/2013 - 08/2000
4Biomarkers (Surrogate Marker)IBA
09/2010 - 04/2006
4Heparin (Liquaemin)FDA LinkGeneric
05/2009 - 04/2002
3Glycoproteins (Glycoprotein)IBA
07/2014 - 12/2001
3ADAMTS13 ProteinIBA
05/2013 - 01/2002
3Factor VIII (Coagulation Factor VIII)IBA
05/2007 - 01/2001
3Intravenous Immunoglobulins (IVIG)FDA Link
02/2004 - 08/2000
2AntibodiesIBA
11/2011 - 01/2001
2CollagenIBA
11/2011 - 06/2001
2Proteins (Proteins, Gene)FDA Link
07/2011 - 06/2001
2lepirudin (Refludan)FDA Link
05/2009 - 05/2009
1AnticoagulantsIBA
09/2016
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2016
1DNA (Deoxyribonucleic Acid)IBA
07/2014
1Complementary DNA (cDNA)IBA
09/2013
1Peptide Hydrolases (Proteases)FDA Link
11/2011
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
05/2011
1LatexIBA
09/2010
1GelsIBA
06/2010
1Adenosine Diphosphate (ADP)IBA
02/2010
1Valproic Acid (Depakote)FDA LinkGeneric
05/2009
1Biological ProductsIBA
05/2009
1Anticonvulsants (Antiepileptic Drugs)IBA
05/2009
1Nonsense Codon (Nonsense Mutation)IBA
05/2007
1LipidsIBA
01/2005
1von Willebrand factor drug combination factor VIIIIBA
02/2004
1Inosine Triphosphate (ITP)IBA
02/2004
1SolventsIBA
01/2002
1Detergents (Detergent)IBA
01/2002
1Hemostatics (Antihemorrhagics)IBA
12/2001
1RistocetinIBA
06/2001
1CoagulantsIBA
06/2001
1Hyaluronic Acid (Hyaluronan)IBA
06/2001
1Immunoglobulin G (IgG)IBA
06/2001
1ParaproteinsIBA
06/2001
1Prednisolone (Predate)FDA LinkGeneric
06/2001
1AutoantibodiesIBA
06/2001
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2001
1Protein Subunits (Protein Subunit)IBA
04/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2000

Therapy/Procedure

10Therapeutics
01/2021 - 01/2002
2Plasmapheresis
12/2007 - 08/2000
1Ligation
05/2011
1Tooth Extraction (Tooth Extractions)
04/2006
1Cesarean Section (Caesarean Section)
08/2005
1Plasma Exchange
01/2002
1Aftercare (After-Treatment)
06/2001
1Drug Therapy (Chemotherapy)
06/2001